Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) (C-Term) Peptide
RIPK1
Reactivity: Human
BP
Sodium azide
Catalog No. ABIN1382186
Quick Overview for Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) (C-Term) Peptide (ABIN1382186)
Target
RIPK1
(Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
Origin
Human
Application
Blocking Peptide (BP)
-
-
Protein Region
- C-Term
-
Characteristics
-
14 amino acids near the carboxy terminus of human RIP1.
Human
-
-
-
-
Application Notes
- RIP1 peptide is used for blocking the activity of RIP1 antibody. It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37 °C.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 200 μg/mL
-
Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Expiry Date
- 12 months
-
-
- RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
Target
-
You are here:
